Uncategorized

Scientists have visualised and investigated a key molecular pathway that could one day help treat inflammation, diabetes, cancer, infectious diseases and potentially even COVID-19. The international collaboration, featuring University of Queensland researchers, isolated and studied the MyD88 molecule and found the missing link between immune cell receptors and the body’s inflammation response. UQ’s Professor Bostjan Kobe said…

University of Queensland scientists have published the clinical trial data confirming their molecular clamp-stabilised vaccine technology was safe and potentially effective. The vaccine candidate developed by the team last year did not progress through to Phase 2/3 clinical trials, due to cross reactivity caused by the protein fragment used to stabilise the clamp design. Initial data…

For the first time in Australia, researchers can accurately predict if babies are at risk of childhood obesity by the age of eight to nine years of age. Researchers from The University of Queensland have developed and validated the i-PATHWAY model, which uses simple risk factors mostly gathered during routine doctor visits at 12 months…

University of Queensland students are the first cohort to experience interprofessional practice education and training in Metro North Hospital and Health Service’s new Surgical, Treatment and Rehabilitation Service (STARS). Metro North and UQ have signed a 20-year partnership to integrate clinical care, education and training, and research in specialist surgical and complex rehabilitation services at…

Traits that allow cancer cells to escape the body’s natural defence system and develop into tumours are actually a good indicator to a patient’s survival prognosis, according to University of Queensland researchers. UQ Diamantina Institute researcher Dr Janin Chandra described the discovery as a “catch-22 situation” and good news for patients with either cervical or head and neck…

A global health organisation and state-of-the-art laboratory at The University of Queensland are collaborating to support the development and evaluation of point-of-care diagnostics for malaria with new custom-made proteins. PATH and UQ’s Protein Expression Facility will supply researchers with malaria proteins to improve point-of-care diagnostic tools and help reduce the burden of malaria, which continues to affect more…